FDA Brief

Warning letters Drugs

FDA warning letter to

Trinity Natural Health & Pain Management, Inc.

High riskIssued Apr 13, 2021Posted Apr 14, 2021Center for Drug Evaluation and Research

FDA and FTC warned Trinity Natural Health over selling an unapproved 'COVID-19 Formula' with claims to prevent or treat COVID-19.

What happened

FDA reviewed the company's website on March 26, 2021, and FTC reviewed it on April 1, 2021; both also reviewed its Facebook page. The site offered a 'COVID-19 Formula' and claimed it could help fight, prevent, or treat COVID-19, including statements about immune boosting and success in patients. FDA says the product is an unapproved new drug and misbranded.

What FDA found

  1. The company sells 'COVID-19 Formula' as a drug to prevent or treat COVID-19 without FDA approval.

    Section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)
  2. The product is misbranded under the FD&C Act.

    Section 502 of the FD&C Act, 21 U.S.C. § 352
  3. The company introduces or delivers the product into interstate commerce despite the prohibition on unapproved and misbranded drugs.

    Sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)
  4. The website and Facebook page claim the herbal formula can prevent, treat, or cure COVID-19 without competent and reliable scientific evidence.

    FTC Act, 15 U.S.C. 41 et seq.

What FDA wants

FDA and FTC ask the company to immediately stop selling and claiming its unapproved COVID-19 product, and to email FDA and FTC within 48 hours with the specific corrective steps taken, steps to prevent recurrence, and supporting documents.

Who should pay attention

  • online sellers of herbal or supplement products
  • consumers who bought COVID-19 Formula
  • platforms hosting product claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk